Another study demonstrated that CCR2 inhibition improves apoptosis by influencing PI3K/AKT and p38MARK signaling pathway in DLBCL (diffuse large B-cell lymphoma) cell lines such as SUDHL-2 and OCI-Ly8 [43]. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.